{
  "trial_id": "NCT00086359",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "HIV infected",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Between the 12th and 30th week of pregnancy",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Intend to continue pregnancy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Viral load less than 55,000 copies/ml within 30 days of study entry",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "CD4 count greater than 350 cells/ml within 30 days of study entry",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Have not previously taken anti-HIV medications (women who have taken 8 weeks or fewer of zidovudine are still eligible) OR have taken anti-HIV medication but have been off treatment for more than 180 days",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Intend to stop taking anti-HIV medications after pregnancy",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Willing to have her infant tested for HIV",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Parent or guardian willing to provide informed consent, if applicable",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Have access to a participating site and are willing to be followed for the duration of the study",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Chemotherapy for active cancer",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Active opportunistic infection or severe medical condition within 14 days of study entry",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Chronic diarrhea within 1 month of study entry or unresolved acute diarrhea within 7 days of study entry",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Certain abnormal laboratory values",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Diabetes mellitus when not pregnant. Participants who have gestational diabetes are not excluded.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Current alcohol or other substance abuse that, in the opinion of the investigator, may interfere with the study",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Acute hepatitis within 90 days of study entry",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Major birth defects in infant",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has myasthenia gravis, class IIa. She takes pyridostigmine 60 mg three times a day and still experiences symptoms that interfere with her job.",
  "_meta": {
    "topic_id": "38",
    "trial_id": "NCT00086359",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}